The impact of pulmonary diseases on the fate of inhaled medicines—A review

YB Wang, AB Watts, JI Peters, RO Williams III - International journal of …, 2014 - Elsevier
The portfolio of compounds approved for inhalation therapy has expanded rapidly for
treatment of lung diseases. To assess the efficacy and safety of inhaled medicines, a better …

Bioavailability and pharmacokinetics of inhaled drugs

AL Adjei, Y Qiu, PK Gupta - Inhalation Aerosols, 2006 - taylorfrancis.com
The evolution of lung drug-delivery technology has undergone significant advances over the
last few decades, so that today it is one of the most effective and rapid modalities for treating …

Aerosol technology to mimic dry powder inhalation in vitro using pulmonary cell models

AM Ledo, S Thibodeaux, L Duong, E Altinoglu… - European Journal of …, 2023 - Elsevier
Inhaled therapy confers key advantages for the treatment of topical pulmonary diseases and
offers potential for systemic delivery of medicines. Dry powder inhalers (DPIs) are generally …

Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound

BM Lue, FS Nielsen, T Magnussen, HM Schou… - European Journal of …, 2008 - Elsevier
The usefulness of selected biorelevant dissolution media (BDM) to predict in vivo drug
absorption was studied. Dissolution profiles of solid formulations of a poorly soluble model …

Comparison and analysis of theoretical models for diffusion-controlled dissolution

Y Wang, B Abrahamsson, L Lindfors… - Molecular …, 2012 - ACS Publications
Dissolution models require, at their core, an accurate diffusion model. The accuracy of the
model for diffusion-dominated dissolution is particularly important with the trend toward …

In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals

K Nahar, N Gupta, R Gauvin, S Absar, B Patel… - European journal of …, 2013 - Elsevier
Delivery of therapeutic agents via the pulmonary route has gained significant attention over
the past few decades because this route of administration offers multiple advantages over …

Utilization of gastrointestinal simulator, an in vivo predictive dissolution methodology, coupled with computational approach to forecast oral absorption of dipyridamole

K Matsui, Y Tsume, S Takeuchi, A Searls… - Molecular …, 2017 - ACS Publications
Weakly basic drugs exhibit a pH-dependent dissolution profile in the gastrointestinal (GI)
tract, which makes it difficult to predict their oral absorption profile. The aim of this study was …

[引用][C] In vitro models of drug dissolution

J Swarbrick - 1970 - Lea & Febiger Philadelphia

Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration

E Nicolaides, M Symillides, JB Dressman… - Pharmaceutical …, 2001 - Springer
Purpose. To quantitatively compare in vitro dissolution data in biorelevant and compendial
media, to investigate whether in vitro differences are reflected in the simulated plasma …

The development of models for the evaluation of pulmonary drug disposition

X Liu, L Jin, JW Upham, MS Roberts - Expert opinion on drug …, 2013 - Taylor & Francis
Introduction: The process of drug disposition in the lung after pulmonary delivery is complex
involving absorptive and non-absorptive mechanisms. The lung has also been suggested to …